Cypress Capital Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,102
| Closed | -$485K | – | 294 |
|
|
2020
Q4 | $485K | Buy |
3,102
+1,020
| +49% | +$159K | 0.07% | 200 |
|
|
2020
Q3 | $238K | Buy |
2,082
+47
| +2% | +$5.37K | 0.04% | 233 |
|
|
2020
Q2 | $228K | Buy |
+2,035
| New | +$228K | 0.04% | 227 |
|
|
2016
Q1 | – | Sell |
-2,333
| Closed | -$445K | – | 186 |
|
|
2015
Q4 | $445K | Hold |
2,333
| – | – | 0.11% | 133 |
|
|
2015
Q3 | $365K | Hold |
2,333
| – | – | 0.09% | 151 |
|
|
2015
Q2 | $422K | Sell |
2,333
-407
| -15% | -$73.6K | 0.1% | 145 |
|
|
2015
Q1 | $475K | Buy |
2,740
+407
| +17% | +$70.6K | 0.11% | 145 |
|
|
2014
Q4 | $432K | Hold |
2,333
| – | – | 0.1% | 148 |
|
|
2014
Q3 | $387K | Hold |
2,333
| – | – | 0.09% | 145 |
|
|
2014
Q2 | $365K | Hold |
2,333
| – | – | 0.09% | 156 |
|
|
2014
Q1 | $355K | Hold |
2,333
| – | – | 0.09% | 155 |
|
|
2013
Q4 | $310K | Hold |
2,333
| – | – | 0.08% | 155 |
|
|
2013
Q3 | $271K | Hold |
2,333
| – | – | 0.07% | 162 |
|
|
2013
Q2 | $215K | Buy |
+2,333
| New | +$215K | 0.04% | 204 |
|